Showing results (1-10 of 82) with videos related to
Sort By:
Pageof 9
Cancers|June 22, 2023
The Role of TRAIL in Apoptosis and Immunosurveillance in CancerJulio M Pimentel, Jun-Ying Zhou, Gen Sheng WuCancer Letters|October 12, 2024
Autophagy and cancer therapyJulio M Pimentel, Jun Ying Zhou, Gen Sheng WuMolecular Carcinogenesis|October 14, 2022
Regulation of programmed death ligand 1 (PD-L1) expression by TNF-related apoptosis-inducing ligand (TRAIL) in triple-negative breast cancer cellsJulio M Pimentel, Jun-Ying Zhou, Gen Sheng WuAmerican Journal of Cancer Research|November 16, 2023
The role of the immune response and inflammatory pathways in TNF-related apoptosis-inducing ligand (TRAIL) resistance in triple-negative breast cancer cellsJulio M Pimentel, Jun-Ying Zhou, Seongho Kim, et al.Current Issues in Molecular Biology|October 28, 2025
Regulation of PD-L1 Protein Expression by the E3 Ubiquitin Ligase GP78Madhumita Chatterjee, Julio M Pimentel, Jun-Ying Zhou, et al.The Journal of Biological Chemistry|May 13, 2011
Bim protein degradation contributes to cisplatin resistanceJuan Wang, Jun-Ying Zhou, Gen Sheng WuCancer Research|October 19, 2006
Tumor necrosis factor-related apoptosis-inducing ligand is required for tumor necrosis factor alpha-mediated sensitization of human breast cancer cells to chemotherapyJing Xu, Jun-Ying Zhou, Gen Sheng WuCancer Research|May 3, 2006
The role of mitogen-activated protein kinase phosphatase-1 in oxidative damage-induced cell deathJun-Ying Zhou, Yusen Liu, Gen Sheng WuCancer Research|December 20, 2007
ERK-dependent MKP-1-mediated cisplatin resistance in human ovarian cancer cellsJuan Wang, Jun-Ying Zhou, Gen Sheng WuCell Cycle (Georgetown, Tex.)|November 19, 2010
Post-translational regulation of mitogen-activated protein kinase phosphatase-2 (MKP-2) by ERKDong-Jun Peng, Jun-Ying Zhou, Gen Sheng WuPageof 9